Download PDF
Thromb Haemost 2009; 101(05): 800-801
DOI: 10.1160/TH09-03-0206
Editorial Focus
Schattauer GmbH

Inflammatory markers for ischaemic stroke

Roberto Pola
1   Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
2   Center for Cardiovascular Research, Department of Medicine, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, Massachussetts, USA
› Author Affiliations
Further Information

Publication History

Received: 30 March 2008

Accepted: 31 March 2009

Publication Date:
24 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
    CrossrefPubMedGoogle Scholar
  • 2 Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
    CrossrefPubMedGoogle Scholar
  • 3 Pearson TA, Mensah GA, Alexander RW. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
    CrossrefPubMedGoogle Scholar
  • 4 Nilsson J. CRP--marker or maker of cardiovascular disease?. Arterioscler Thromb Vasc Biol 2005; 25: 1527-1528.
    CrossrefPubMedGoogle Scholar
  • 5 Bisoendial RJ, Kastelein JJ, Levels JH. et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005; 96: 714-716.
    CrossrefPubMedGoogle Scholar
  • 6 Hashimoto H, Kitagawa K, Hougaku H. et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001; 104: 63-67.
    CrossrefPubMedGoogle Scholar
  • 7 Ford ES, Giles WH. Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol 2000; 20: 1052-1056.
    CrossrefPubMedGoogle Scholar
  • 8 Muir KW, Weir CJ, Alwan W. et al. C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30: 981-985.
    CrossrefPubMedGoogle Scholar
  • 9 Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001; 32: 917-924.
    CrossrefPubMedGoogle Scholar
  • 10 Winbeck K, Poppert H, Etgen T. et al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459-2464.
    CrossrefPubMedGoogle Scholar
  • 11 Fisman EZ, Benderly M, Esper RJ. et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006; 98: 14-18.
    PubMedGoogle Scholar
  • 12 Blankenberg S, Tiret L, Bickel C. et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
    CrossrefPubMedGoogle Scholar
  • 13 Shai I, Schulze MB, Manson JE. et al. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 2005; 28: 1376-1382.
    CrossrefPubMedGoogle Scholar
  • 14 Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
    CrossrefPubMedGoogle Scholar
  • 15 Licata G, Tuttolomondo A, Di Raimondo D. et al. Immuno-inflammatory activation in acute cardio-embolic stroke in comparison with other subtypes of stroke. Thromb Haemost 2009; 101: 929-937.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Aviles RJ, Martin DO, Apperson-Hansen C. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
    CrossrefPubMedGoogle Scholar